Biotech
Biotech Breakthrough Verdiva Raises $410M to Revolutionize Obesity Treatment with Game-Changing Weight Loss Drug
Verdiva, a biotechnology company, has burst onto the scene with a staggering $410 million Series A funding round. This monumental...
Read more
Biotech Breakthrough: Vertex Partners with Orna Therapeutics in $65 Million Gene Therapy Deal
Vertex Pharmaceuticals, a renowned biotechnology company, has made a significant investment in Orna Therapeutics, acquiring a $65 million stake. This...
Read more
Oculis’ Peptidomimetic Shows Promise in Protecting Eyes from Optic Nerve Inflammation
Oculis, a pioneering ophthalmic biotech company, has achieved a significant milestone in its quest to safeguard vision. The company's innovative...
Read more
Xeno’s Biotech Expertise Yields Promising C. diff Treatment with LPOXY
Xeno, a biotech company, recently faced a setback with its gastric-bypass alternative, prompting a strategic pivot. The company's focus now...
Read more
Withings Omnia Redefines Biomedical Imaging with AI-Powered Body Scanning
Withings, a pioneering health technology company, has unveiled its latest innovation – Omnia, a full-size body-scanning health mirror. This revolutionary...
Read more
Biotech Firm Unveils Revolutionary Alzheimer’s Vaccine
Regeneron Pharmaceuticals, Inc. has made a significant move in the biotechnology landscape with its acquisition of UK-based Oxular Limited. This...
Read more
Humacyte’s Bioengineered Artery Implant Revolutionizes Vascular Trauma Repair
The FDA's approval of Humacyte's off-the-shelf artery implant marks a significant breakthrough in vascular trauma repair. This innovative solution addresses...
Read more
Proton’s Revolutionary Device Tackles Kidney Disease, Cuts Heart Failure Risk”l
Proton's innovative medical device is poised to transform the lives of individuals suffering from kidney disease, while also reducing the...
Read more
Gilead Partners with Terray Therapeutics in $120M Biotech Deal to Accelerate Innovative Therapies
Fresh off a $120 million raise, AI-powered biotech company Terray Therapeutics has announced a significant research and development (R&D) partnership...
Read more
Biotech Blowup for BioAge’s Obesity Drug
BioAge's recent announcement that its phase 2 obesity study has been derailed by liver side effects has sent shockwaves through...
Read more
